MilliporeSigma Launches Plug & Play Upstream Development Service

Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-ups

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has launched its Plug & Play Upstream Development Service to help emerging biotech and start-up companies optimize the cost and speed of advancing their molecule to the clinical stage.             Eliminating the need to work with multiple vendors for upstream development, the new service aims to reduce bottlenecks, lowering time to clinic by two months. The Plug & Play Upstream Development Service includes cell line development, standard analytics, early material from sta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters